表紙
市場調查報告書

精準醫學市場報告(2020-2030):按治療,技術和最終用戶,主要公司概況,區域和主要市場分析進行的預測

Precision Medicine Market Report 2020-2030: Forecasts by Therapeutics, by Technology, by End Users, Profiles of Leading Companies, Regional and Leading National Market Analysis

出版商 Visiongain Ltd 商品編碼 950685
出版日期 內容資訊 英文 375 Pages
商品交期: 最快1-2個工作天內
價格
精準醫學市場報告(2020-2030):按治療,技術和最終用戶,主要公司概況,區域和主要市場分析進行的預測 Precision Medicine Market Report 2020-2030: Forecasts by Therapeutics, by Technology, by End Users, Profiles of Leading Companies, Regional and Leading National Market Analysis
出版日期: 2020年05月27日內容資訊: 英文 375 Pages
簡介

除了預測到2030年的利潤,近期業績,增長率,市場份額和定性分析(市場動態,增長因素,機會,我們提供的信息包括主要公司的限制,問題和資料。

內容

第1章調查大綱

第2章市場範圍:精密醫學

  • 精準醫學市場的定義
  • 精密藥品市場:介紹
  • 精密醫學的發展與歷史
  • 精準醫學的主要優勢
  • 精密醫學:主要應用領域
  • 精準醫學:重要因素
  • 精準醫學:大數據公司使用的不同類型的數據
  • 精準醫學:關注領域

第3章全球精密藥物市場概述

  • 市場動態
    • 促進要因
    • 精密藥品市場面臨的挑戰
    • 精準醫學市場面臨的局限性
    • 主要機會
  • SWOT分析
    • 實力
    • 弱點
    • 市場機會
    • 威脅
  • 行業分析:波特
    • 競爭
    • 供應商力量
    • 買方力量
    • 來自代理商的威脅
    • 新進入的威脅
  • 行業分析:PEST
    • 政治性
    • 經濟
    • 社交
    • 技術
  • 價值鏈分析
    • 設備製造商和藥品製造商
    • 醫療保健提供者
    • 醫療保健IT或大數據公司
    • 監管機構
    • 第三方保險公司
    • 患者
  • COVID-19影響分析
    • 精準醫學的作用
    • 評估癌症患者並確定治療優先級(高,中,低優先級)
    • 按治療分列的全球精密醫學市場預測(COVID-19之前)
    • 按技術分類的全球精準醫學市場預測(COVID-19之前)
    • 最終用戶對全球精準醫學市場的預測(COVID-19之前)
    • 按地區分列的全球精準醫學市場預測(COVID-19之前)

第4章按治療方法預測的全球精準醫學市場規模

  • 癌症
    • 恢復預測
  • 心血管
  • CNS
  • 傳染病
  • 免疫學
  • 其他

第5章按技術預測的全球精準醫學市場規模

  • 綜合診斷
    • 恢復預測
  • 生物標誌物
  • 靶向治療中的生物庫
  • 藥物基因組學
  • 分子診斷

第6章最終用戶對全球精準醫學市場規模的預測

  • 製藥和生物技術
  • 診斷工具公司
  • 醫療保健IT/大數據公司
  • 臨床實驗室

第7章北美精準醫學市場

  • 按國家/地區劃分的市場收益預測
  • 按治療方法預測的市場收益
  • 按技術預測市場收入
  • 最終用戶的市場收入預測
  • 美國
    • 恢復預測
  • 加拿大

第8章歐洲精密藥物市場

  • 按國家/地區劃分的市場收益預測
  • 按治療方法預測的市場收益
  • 按技術預測市場收入
  • 最終用戶的市場收入預測
  • 德國
    • 恢復預測
  • 法國
  • 英國
  • 意大利
  • 西班牙
  • 比利時
  • 瑞士
  • 其他歐洲

第9章亞太精準醫學市場

  • 按國家/地區劃分的市場收益預測
  • 按治療方法預測的市場收益
  • 按技術預測市場收入
  • 最終用戶的市場收入預測
  • 日本
    • 恢復預測
  • 中國
  • 印度
  • 澳大利亞
  • 新加坡
  • 菲律賓
  • 韓國
  • 其他亞太地區

第10章北美精準醫學市場

  • 按國家/地區劃分的市場收益預測
  • 按治療方法預測的市場收益
  • 按技術預測市場收入
  • 最終用戶的市場收入預測
  • 巴西
    • 恢復預測
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲

第11章中東和非洲精準醫學市場

  • 按國家/地區劃分的市場收益預測
  • 按治療方法預測的市場收益
  • 按技術預測市場收入
  • 最終用戶的市場收入預測
  • 阿拉伯聯合酋長國
    • 恢復預測
  • 沙特阿拉伯
  • 南非
  • 其他中東和非洲

第12章精準醫學市場的主要公司

  • Abbott
  • GE Healthcare
  • Johnson & Johnson Services, Inc.
  • Pfizer Inc.
  • Laboratory Corporation of America Holdings
  • Danaher
  • Qiagen N.V.
  • Thermo Fisher Scientific Inc.
  • Illumina Inc.
  • Novartis AG
  • GSK
  • Merck KGaA
  • F. Hoffmann-La Roche Ltd.
  • Amgen Inc.

第13章結論和建議

目錄
Product Code: PHA0741

Title:
Precision Medicine Market Report 2020-2030
Forecasts by Therapeutics (Cancer, Cardiovascular, Central Nervous System, Infectious Diseases, Immunology, Others), by Technology (Companion Diagnostics, Biomarkers, Biobanking in Targeted Therapeutics, Pharmacogenomics, Molecular Diagnostics), by End Users (Pharma & Biotech, Diagnostic Tool Companies, Healthcare IT/Big Data Companies, Clinical Laboratories), Profiles of Leading Companies and Regional and Leading National Market Analysis.

Precision Medicine-our new study reveals trends, R&D progress, and predicted revenues

Where is the Precision Medicine market heading? If you are involved in this sector you must read this newly updated report. Visiongain's report shows you the potential revenues streams to 2030, assessing data, trends, opportunities and business prospects there.

Discover how to stay ahead

Our 375 pages report provides 271 tables, 267 charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Precision Medicine Market. See how to exploit the opportunities.

This report includes data analysis and invaluable insight into how COVID-19 will affect your industry. Access this report today.

Forecasts to 2030 and other analyses reveal the commercial prospects

  • In addition to revenue forecasting to 2030, our new study provides you with recent results, growth rates, and market shares.
  • You find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.

Discover sales predictions for the world market and submarkets

Along with revenue prediction for the overall world market, there are following segments, each forecasted at a global and regional level.

Precision Medicine Market by Therapeutics

  • Cancer
  • Cardiovascular
  • Central Nervous System
  • Infectious Diseases
  • Immunology
  • Others

Precision Medicine Market by Technology

  • Companion Diagnostics
  • Biomarkers
  • Biobanking in Targeted Therapeutics
  • Pharmacogenomics
  • Molecular Diagnostics

Precision Medicine Market by End Users

  • Pharma & Biotech
  • Diagnostic Tool Companies
  • Healthcare IT/Big Data Companies
  • Clinical Laboratories

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 22 leading national markets:

North America

  • U.S.
  • Canada

Europe

  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Belgium
  • Switzerland
  • Rest of Europe

Asia Pacific

  • Japan
  • China
  • India
  • Australia
  • Singapore
  • The Philippines
  • South Korea
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America

Middle East and Africa

  • UAE
  • Saudi Arabia
  • South Africa
  • Rest of MEA

The report also includes profiles and for some of the leading companies in the Precision Medicine market, with a focus on this segment of these companies' operations.

Leading companies and the potential for market growth

Overall world revenue for Precision Medicine Market will surpass $67 billion in 2020, our work calculates. We predict strong revenue growth through to 2030.

Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How the Precision Medicine Market report helps you

In summary, our 375 pages report provides you with the following knowledge:

  • Revenue forecasts to 2030 for 5 regional and 22 key national markets- See forecasts for the Precision Medicine market in North America, Latin America, Europe, Asia-Pacific and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Argentina, Germany, France, UK, Italy, Spain, Belgium, Switzerland, China, India, Japan, Australia, Singapore, The Philippines, South Korea. UAE, Saudi Arabia and South Africa.
  • Prospects for established firms and those seeking to enter the market- including company profiles for 14 of the major companies involved in the Precision Medicine market i.e. Abbott, GE Healthcare, Johnson & Johnson Services, Inc., Pfizer Inc., Laboratory Corporation of America Holdings, Danaher, Qiagen N.V., Thermo Fisher Scientific Inc., Illumina, Inc., Novartis AG, GSK, Merck KGaA, F. Hoffmann-La Roche Ltd, and Amgen Inc.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else

With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions.

Visiongain's study is for everybody needing commercial analyses for the Precision Medicine market and leading companies. You will find data, trends and predictions.

Get our report today Precision Medicine Market Report 2020-2030: Forecasts by Therapeutics (Cancer, Cardiovascular, Central Nervous System, Infectious Diseases, Immunology, Others), by Technology (Companion Diagnostics, Biomarkers, Biobanking in Targeted Therapeutics, Pharmacogenomics, Molecular Diagnostics), by End Users (Pharma & Biotech, Diagnostic Tool Companies, Healthcare IT/Big Data Companies, Clinical Laboratories), Profiles of Leading Companies and Regional and Leading National Market Analysis.

Visiongain is a trading partner with the US Federal Government.

Table of Contents

1 Report Overview

  • 1.1 Why You Should Read This Report
  • 1.2 What This Report Delivers
  • 1.3 Key Questions Answered by This Analytical Report Include:
  • 1.4 Who is This Report For?
  • 1.5 Methodology
  • 1.6 Frequently Asked Questions (FAQs)
  • 1.7 Associated Visiongain Reports
  • 1.8 About Visiongain

2 Market Scope: Precision Medicine

  • 2.1 Precision Medicine Market Definition
  • 2.2 Precision Medicine Market: Introduction
  • 2.3 Evolution and Brief History of Precision Medicine
  • 2.4 Key Benefits of Precision Medicine
  • 2.5 Precision Medicine: Key Areas of Application
  • 2.6 Precision Medicine: Key Elements
  • 2.7 Precision Medicine: Different Type of Data Used by Big Data Companies
  • 2.8 Precision Medicine: Area of Interest

3 Global Precision Medicine Market Overview

  • 3.1 Market Dynamics
    • 3.1.1 Drivers
    • 3.1.2 Challenges Faced by Precision Medicine Market
    • 3.1.3 Restraints Faced by Precision Medicine Market
    • 3.1.4 Key Opportunities
  • 3.2 SWOT Analysis
    • 3.2.1 Strengths
    • 3.2.2 Weaknesses
    • 3.2.3 Opportunities
    • 3.2.4 Threats
  • 3.3 Industry analysis - Porter's
    • 3.3.1 Degree of competition
    • 3.3.2 Supplier power
    • 3.3.3 Buyer power
    • 3.3.4 Threat from substitutes
    • 3.3.5 Threat of new entrants
  • 3.4 Industry analysis - PEST
    • 3.4.1 Political
    • 3.4.2 Economical
    • 3.4.3 Social
    • 3.4.4 Technological
  • 3.5 Value Chain Analysis
    • 3.5.1 Device Manufacturer & Drug Producers
    • 3.5.2 Healthcare Providers
    • 3.5.3 Healthcare IT Or Big Data Companies
    • 3.5.4 Regulators
    • 3.5.5 Third Party Payers
    • 3.5.6 Patients
  • 3.6 COVID-19 Impact Analysis
    • 3.6.1 Role of Precision Medicine
    • 3.6.2 Cancer Patients Assessment and Treatment Priority Determination (Top, Intermediate & Low Priority)
    • 3.6.3 Global Precision Medicine Market Forecast by Therapeutics, (Pre-COVID-19)
    • 3.6.4 Global Precision Medicine Market Forecast by Technology, (Pre-COVID-19)
    • 3.6.5 Global Precision Medicine Market Forecast by End-Users, (Pre-COVID-19)
    • 3.6.6 Global Precision Medicine Market Forecast by Region, (Pre-COVID-19)

4 Global Precision Medicine Market Size Forecast 2020-2030 by Therapeutics

  • 4.1 Cancer
    • 4.1.1 Recovery Forecast, 2020-2030 (V, U, W, L)
  • 4.2 Cardiovascular
    • 4.2.1 Recovery Forecast, 2020-2030 (V, U, W, L)
  • 4.3 CNS
    • 4.3.1 Recovery Forecast, 2020-2030 (V, U, W, L)
  • 4.4 Infectious Diseases
    • 4.4.1 Recovery Forecast, 2020-2030 (V, U, W, L)
  • 4.5 Immunology
    • 4.5.1 Recovery Forecast, 2020-2030 (V, U, W, L)
  • 4.6 Others
    • 4.6.1 Recovery Forecast, 2020-2030 (V, U, W, L)

5 Global Precision Medicine Market Size Forecast 2020-2030 by Technology

  • 5.1 Companion Diagnostics
    • 5.1.1 Recovery Forecast, 2020-2030 (V, U, W, L)
  • 5.2 Biomarkers
    • 5.2.1 Recovery Forecast, 2020-2030 (V, U, W, L)
  • 5.3 Biobanking in Targeted Therapeutics
    • 5.3.1 Recovery Forecast, 2020-2030 (V, U, W, L)
  • 5.4 Pharmacogenomics
    • 5.4.1 Recovery Forecast, 2020-2030 (V, U, W, L)
  • 5.5 Molecular Diagnostics
    • 5.5.1 Recovery Forecast, 2020-2030 (V, U, W, L)

6 Global Precision Medicine Market Size Forecast 2020-2030 by End Users

  • 6.1 Pharma & Biotech
    • 6.1.1 Recovery Forecast, 2020-2030 (V, U, W, L)
  • 6.2 Diagnostic Tool Companies
    • 6.2.1 Recovery Forecast, 2020-2030 (V, U, W, L)
  • 6.3 Healthcare IT/Big Data Companies
    • 6.3.1 Recovery Forecast, 2020-2030 (V, U, W, L)
  • 6.4 Clinical Laboratories
    • 6.4.1 Recovery Forecast, 2020-2030 (V, U, W, L)

7 North America Precision Medicine Market

  • 7.1 North America Precision Medicine Market by Country Revenue Forecast, 2020-2030
  • 7.2 North America Precision Medicine Market Forecast by Therapeutics, 2020-2030
  • 7.3 North America Precision Medicine Market Forecast by Technology, 2020-2030
  • 7.4 North America Precision Medicine Market Forecast by End Users, 2020-2030
  • 7.5 U.S.
    • 7.5.1 Recovery Forecast, 2020-2030 (V, U, W, L)
  • 7.6 Canada
    • 7.6.1 Recovery Forecast, 2020-2030 (V, U, W, L)

8 Europe Precision Medicine Market by Country Revenue Forecast, 2020-2030

  • 8.1 Europe Precision Medicine Market Forecast by Therapeutics, 2020-2030
  • 8.2 Europe Precision Medicine Market Forecast by Technology, 2020-2030
  • 8.3 Europe Precision Medicine Market Forecast by End Users, 2020-2030
  • 8.4 Germany
    • 8.4.1 Recovery Forecast, 2020-2030 (V, U, W, L)
  • 8.5 France
    • 8.5.1 Recovery Forecast, 2020-2030 (V, U, W, L)
  • 8.6 UK
    • 8.6.1 Recovery Forecast, 2020-2030 (V, U, W, L)
  • 8.7 Italy
    • 8.7.1 Recovery Forecast, 2020-2030 (V, U, W, L)
  • 8.8 Spain
    • 8.8.1 Recovery Forecast, 2020-2030 (V, U, W, L)
  • 8.9 Belgium
    • 8.9.1 Recovery Forecast, 2020-2030 (V, U, W, L)
  • 8.10 Switzerland
    • 8.10.1 Recovery Forecast, 2020-2030 (V, U, W, L)
  • 8.11 Rest of Europe
    • 8.11.1 Recovery Forecast, 2020-2030 (V, U, W, L)

9 Asia Pacific Precision Medicine Market by Country Revenue Forecast, 2020-2030

  • 9.1 Asia Pacific Precision Medicine Market Forecast by Therapeutics, 2020-2030
  • 9.2 Asia Pacific Precision Medicine Market Forecast by Technology, 2020-2030
  • 9.3 Asia Pacific Precision Medicine Market Forecast by End Users, 2020-2030
  • 9.4 Japan
    • 9.4.1 Recovery Forecast, 2020-2030 (V, U, W, L)
  • 9.5 China
    • 9.5.1 Recovery Forecast, 2020-2030 (V, U, W, L)
  • 9.6 India
    • 9.6.1 Recovery Forecast, 2020-2030 (V, U, W, L)
  • 9.7 Australia
    • 9.7.1 Recovery Forecast, 2020-2030 (V, U, W, L)
  • 9.8 Singapore
    • 9.8.1 Recovery Forecast, 2020-2030 (V, U, W, L)
  • 9.9 The Philippines
    • 9.9.1 Recovery Forecast, 2020-2030 (V, U, W, L)
  • 9.10 South Korea
    • 9.10.1 Recovery Forecast, 2020-2030 (V, U, W, L)
  • 9.11 Rest of Asia Pacific
    • 9.11.1 Recovery Forecast, 2020-2030 (V, U, W, L)

10 Latin America Precision Medicine Market by Country Revenue Forecast, 2020-2030

  • 10.1 Latin America Precision Medicine Market Forecast by Therapeutics, 2020-2030
  • 10.2 Latin America Precision Medicine Market Forecast by Technology, 2020-2030
  • 10.3 Latin America Precision Medicine Market Forecast by End Users, 2020-2030
  • 10.4 Brazil
    • 10.4.1 Recovery Forecast, 2020-2030 (V, U, W, L)
  • 10.5 Mexico
    • 10.5.1 Recovery Forecast, 2020-2030 (V, U, W, L)
  • 10.6 Argentina
    • 10.6.1 Recovery Forecast, 2020-2030 (V, U, W, L)
  • 10.7 Rest of Latin America
    • 10.7.1 Recovery Forecast, 2020-2030 (V, U, W, L)

11 Middle East and Africa Precision Medicine Market by Country Revenue Forecast, 2020-2030

  • 11.1 Middle East and Africa Precision Medicine Market Forecast by Therapeutics, 2020-2030
  • 11.2 Middle East and Africa Precision Medicine Market Forecast by Technology, 2020-2030
  • 11.3 Middle East and Africa Precision Medicine Market Forecast by End Users, 2020-2030
  • 11.4 UAE
    • 11.4.1 Recovery Forecast, 2020-2030 (V, U, W, L)
  • 11.5 Saudi Arabia
    • 11.5.1 Recovery Forecast, 2020-2030 (V, U, W, L)
  • 11.6 South Africa
    • 11.6.1 Recovery Forecast, 2020-2030 (V, U, W, L)
  • 11.7 Rest of Middle East and Africa
    • 11.7.1 Recovery Forecast, 2020-2030 (V, U, W, L)

12 Leading Companies in the Precision Medicine Market

  • 12.1 Abbott
    • 12.1.1 Company Overview
    • 12.1.2 Financials, 2015-2019 (US$ million, AGR %)
    • 12.1.3 Products / Services
    • 12.1.4 Mergers & Acquisitions (M&A) Activity
  • 12.2 GE Healthcare
    • 12.2.1 Company Overview
    • 12.2.2 Financials, 2015-2019 (US$ million, AGR %)
    • 12.2.3 Products / Services
    • 12.2.4 Mergers & Acquisitions (M&A) Activity
  • 12.3 Johnson & Johnson Services, Inc.
    • 12.3.1 Company Overview
    • 12.3.2 Financials, 2015-2019 (US$ million, AGR %)
    • 12.3.3 Products / Services
    • 12.3.4 Mergers & Acquisitions (M&A) Activity
  • 12.4 Pfizer Inc.
    • 12.4.1 Company Overview
    • 12.4.2 Financials, 2015-2019 (US$ million, AGR %)
    • 12.4.3 Products / Services
    • 12.4.4 Mergers & Acquisitions (M&A) Activity
  • 12.5 Laboratory Corporation of America Holdings
    • 12.5.1 Company Overview
    • 12.5.2 Financials, 2015-2019 (US$ million, AGR %)
    • 12.5.3 Products / Services
    • 12.5.4 Mergers & Acquisitions (M&A) Activity
  • 12.6 Danaher
    • 12.6.1 Company Overview
    • 12.6.2 Financials, 2015-2019 (US$ million, AGR %)
    • 12.6.3 Products / Services
    • 12.6.4 Mergers & Acquisitions (M&A) Activity
  • 12.7 Qiagen N.V.
    • 12.7.1 Company Overview
    • 12.7.2 Financials, 2015-2019 (US$ million, AGR %)
    • 12.7.3 Products / Services
    • 12.7.4 Mergers & Acquisitions (M&A) Activity
  • 12.8 Thermo Fisher Scientific Inc.
    • 12.8.1 Company Overview
    • 12.8.2 Financials, 2015-2019 (US$ million, AGR %)
    • 12.8.3 Products / Services
    • 12.8.4 Mergers & Acquisitions (M&A) Activity
  • 12.9 Illumina Inc.
    • 12.9.1 Company Overview
    • 12.9.2 Total Company Sales 2015-2019
    • 12.9.3 Products / Services
    • 12.9.4 Mergers & Acquisitions (M&A) Activity
  • 12.10 Novartis AG
    • 12.10.1 Company Overview
    • 12.10.2 Total Company Sales, 2015-2018
    • 12.10.3 Products / Services
    • 12.10.4 Mergers & Acquisitions (M&A) Activity
  • 12.11 GSK
    • 12.11.1 Company Overview
    • 12.11.2 Financials, 2015-2019 (US$ million, AGR %)
    • 12.11.3 Products / Services
    • 12.11.4 Mergers & Acquisitions (M&A) Activity
  • 12.12 Merck KGaA
    • 12.12.1 Company Overview
    • 12.12.2 Financials, 2015-2019 (US$ million, AGR %)
    • 12.12.3 Products / Services
    • 12.12.4 Mergers & Acquisitions (M&A) Activity
  • 12.13 F. Hoffmann-La Roche Ltd.
    • 12.13.1 Company Overview
    • 12.13.2 Financials, 2015-2019 (US$ million, AGR %)
    • 12.13.3 Precision Medicine Products / Services
    • 12.13.4 Mergers & Acquisitions (M&A) Activity
  • 12.14 Amgen Inc.
    • 12.14.1 Company Overview
    • 12.14.2 Financials, 2015-2019 (US$ million, AGR %)
    • 12.14.3 Products / Services
    • 12.14.4 Mergers & Acquisitions (M&A) Activity

13 Conclusions and Recommendations

  • Associated Visiongain Reports
  • Visiongain Report Sales Order Form
  • Appendix A: About Visiongain
  • Appendix B: Visiongain report evaluation form

List of Tables

  • Table 1. Global Precision Medicine Market CAGR Forecast by Region 2020, 2025, 2030 (CAGR %)
  • Table 2. Key Benefits of Precision Medicine
  • Table 3. Key Elements of Precision Medicine
  • Table 4. Global Precision Medicine Market Forecast by Therapeutics (Pre-COVID- 19), 2020-2030 (US$ billion, AGR %, CAGR %)
  • Table 5. Global Precision Medicine Market Forecast by Technology (Pre-COVID-19), 2020-2030 (US$ billion, AGR %, CAGR %)
  • Table 6. Global Precision Medicine Market Forecast by End Users (Pre-COVID-19), 2020-2030 (US$ billion, AGR %, CAGR %)
  • Table 7. Global Precision Medicine Market Forecast by Region (Pre-COVID-19), 2020-2030 (US$ billion, AGR %, CAGR %)
  • Table 8. Global Precision Medicine Market Forecast by Therapeutics, 2020-2030 (US$ billion, AGR %, CAGR %)
  • Table 9. Cancer Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 10. Cancer Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): V Shaped Recovery
  • Table 11. Cancer Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): U Shaped Recovery
  • Table 12. Cancer Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): W Shaped Recovery
  • Table 13. Cancer Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): L Shaped Recovery
  • Table 14. Cardiovascular Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 15. Cardiovascular Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): V Shaped Recovery
  • Table 16. Cardiovascular Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): U Shaped Recovery
  • Table 17. Cardiovascular Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): W Shaped Recovery
  • Table 18. Cardiovascular Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): L Shaped Recovery
  • Table 19. CNS Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 20. CNS Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): V Shaped Recovery
  • Table 21. CNS Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): U Shaped Recovery
  • Table 22. CNS Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): W Shaped Recovery
  • Table 23. CNS Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): L Shaped Recovery
  • Table 24. Infectious Diseases Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 25. Infectious Diseases Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): V Shaped Recovery
  • Table 26. Infectious Diseases Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): U Shaped Recovery
  • Table 27. Infectious diseases Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): W Shaped Recovery
  • Table 28. Infectious Diseases Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): L Shaped Recovery
  • Table 29. Immunology Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 30. Immunology Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): V Shaped Recovery
  • Table 31. Immunology Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): U Shaped Recovery
  • Table 32. Immunology Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): W Shaped Recovery
  • Table 33. Immunology Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): L Shaped Recovery
  • Table 34. Others Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 35. Others Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): V Shaped Recovery
  • Table 36. Others Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): U Shaped Recovery
  • Table 37. Others Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): W Shaped Recovery
  • Table 38. Others Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): L Shaped Recovery
  • Table 39. Global Precision Medicine Market Forecast by Technology, 2020-2030 (US$ billion, AGR %, CAGR %)
  • Table 40. Companion Diagnostics Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 41. Companion diagnostics Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): V Shaped Recovery
  • Table 42. Companion diagnostics Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): U Shaped Recovery
  • Table 43. Companion diagnostics Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): W Shaped Recovery
  • Table 44. Companion diagnostics Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): L Shaped Recovery
  • Table 45. Biomarkers Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 46. Biomarkers Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): V Shaped Recovery
  • Table 47. Biomarkers Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): U Shaped Recovery
  • Table 48. Biomarkers Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): W Shaped Recovery
  • Table 49. Biomarkers Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): L Shaped Recovery
  • Table 50. Biobanking in Targeted Therapeutics Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 51. Biobanking in Targeted Therapeutics Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): V Shaped Recovery
  • Table 52. Biobanking in Targeted Therapeutics Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): U Shaped Recovery
  • Table 53. Biobanking in Targeted Therapeutics Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): W Shaped Recovery
  • Table 54. Biobanking in Targeted Therapeutics Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): L Shaped Recovery
  • Table 55. Pharmacogenomics Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 56. Pharmacogenomics Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): V Shaped Recovery
  • Table 57. Pharmacogenomics Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): U Shaped Recovery
  • Table 58. Pharmacogenomics Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): W Shaped Recovery
  • Table 59. Pharmacogenomics Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): L Shaped Recovery
  • Table 60. Molecular Diagnostics Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 61. Molecular Diagnostics Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): V Shaped Recovery
  • Table 62. Molecular Diagnostics Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): U Shaped Recovery
  • Table 63. Molecular Diagnostics Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): W Shaped Recovery
  • Table 64. Molecular Diagnostics Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): L Shaped Recovery
  • Table 65. Global Precision Medicine Market Forecast by End Users, 2020-2030 (US$ billion, AGR %, CAGR %)
  • Table 66. Pharma & Biotech Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 67. Pharma & Biotech Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): V Shaped Recovery
  • Table 68. Pharma & Biotech Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): U Shaped Recovery
  • Table 69. Pharma & Biotech Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): W Shaped Recovery
  • Table 70. Pharma & Biotech Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): L Shaped Recovery
  • Table 71. Diagnostic Tool Companies Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 72. Diagnostic Tool Companies Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): V Shaped Recovery
  • Table 73. Diagnostic Tool Companies Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): U Shaped Recovery
  • Table 74. Diagnostic Tool Companies Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): W Shaped Recovery
  • Table 75. Diagnostic Tool Companies Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): L Shaped Recovery
  • Table 76. Healthcare IT/Big Data Companies Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 77. Healthcare IT/Big Data Companies Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): V Shaped Recovery
  • Table 78. Healthcare IT/Big Data Companies Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): U Shaped Recovery
  • Table 79. Healthcare IT/Big Data Companies Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): W Shaped Recovery
  • Table 80. Healthcare IT/Big Data Companies Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): L Shaped Recovery
  • Table 81. Clinical Laboratories Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 82. Clinical Laboratories Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): V Shaped Recovery
  • Table 83. Clinical Laboratories Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): U Shaped Recovery
  • Table 84. Clinical Laboratories Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): W Shaped Recovery
  • Table 85. Clinical Laboratories Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): L Shaped Recovery
  • Table 86. North America Precision Medicine Market Forecast by Therapeutics, 2020- 2030 (US$ billion, AGR %, CAGR %)
  • Table 87. North America Precision Medicine Market Forecast by Technology, 2020- 2030 (US$ billion, AGR %, CAGR %)
  • Table 88. North America Precision Medicine Market Forecast by End Users, 2020- 2030 (US$ billion, AGR %, CAGR %)
  • Table 89. U.S. Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
  • Table 90. U.S. Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): V Shaped Recovery
  • Table 91. U.S. Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): U Shaped Recovery
  • Table 92. U.S. Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): W Shaped Recovery
  • Table 93. U.S. Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): L Shaped Recovery
  • Table 94. Canada Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
  • Table 95. Canada Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): V Shaped Recovery
  • Table 96. Canada Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): U Shaped Recovery
  • Table 97. Canada Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): W Shaped Recovery
  • Table 98. Canada Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): L Shaped Recovery
  • Table 99. Europe Precision Medicine Market Forecast by Therapeutics, 2020-2030 (US$ billion, AGR %, CAGR %)
  • Table 100. Europe Precision Medicine Market Forecast by Technology, 2020-2030 (US$ billion, AGR %, CAGR %)
  • Table 101. Europe Precision Medicine Market Forecast by End Users, 2020-2030 (US$ billion, AGR %, CAGR %)
  • Table 102. Germany Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
  • Table 103. Germany Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): V Shaped Recovery
  • Table 104. Germany Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): U Shaped Recovery
  • Table 105. Germany Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): W Shaped Recovery
  • Table 106. Germany Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): L Shaped Recovery
  • Table 107. France Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
  • Table 108. France Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): V Shaped Recovery
  • Table 109. France Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): U Shaped Recovery
  • Table 110. France Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): W Shaped Recovery
  • Table 111. France Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): L Shaped Recovery
  • Table 112. UK Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
  • Table 113. UK Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): V Shaped Recovery
  • Table 114. UK Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): U Shaped Recovery
  • Table 115. UK Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): W Shaped Recovery
  • Table 116. UK Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): L Shaped Recovery
  • Table 117. Italy Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
  • Table 118. Italy Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): V Shaped Recovery
  • Table 119. Italy Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): U Shaped Recovery
  • Table 120. Italy Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): W Shaped Recovery
  • Table 121. Italy Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): L Shaped Recovery
  • Table 122. Spain Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
  • Table 123. Spain Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): V Shaped Recovery
  • Table 124. Spain Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): U Shaped Recovery
  • Table 125. Spain Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): W Shaped Recovery
  • Table 126. Spain Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): L Shaped Recovery
  • Table 127. Belgium Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
  • Table 128. Belgium Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): V Shaped Recovery
  • Table 129. Belgium Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): U Shaped Recovery
  • Table 130. Belgium Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): W Shaped Recovery
  • Table 131. Belgium Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): L Shaped Recovery
  • Table 132. Switzerland Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
  • Table 133. Switzerland Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): V Shaped Recovery
  • Table 134. Switzerland Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): U Shaped Recovery
  • Table 135. Switzerland Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): W Shaped Recovery
  • Table 136. Switzerland Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): L Shaped Recovery
  • Table 137. Rest of Europe Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
  • Table 138. Rest of Europe Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): V Shaped Recovery
  • Table 139. Rest of Europe Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): U Shaped Recovery
  • Table 140. Rest of Europe Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): W Shaped Recovery
  • Table 141. Rest of Europe Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): L Shaped Recovery
  • Table 142. Asia Pacific Precision Medicine Market Forecast by Therapeutics, 2020- 2030 (US$ billion, AGR %, CAGR %)
  • Table 143. Asia Pacific Precision Medicine Market Forecast by Technology, 2020- 2030 (US$ billion, AGR %, CAGR %)
  • Table 144. Asia Pacific Precision Medicine Market Forecast by End Users, 2020- 2030 (US$ billion, AGR %, CAGR %)
  • Table 145. Japan Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
  • Table 146. Japan Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): V Shaped Recovery
  • Table 147. Japan Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): U Shaped Recovery
  • Table 148. Japan Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): W Shaped Recovery
  • Table 149. Japan Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): L Shaped Recovery
  • Table 150. China Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
  • Table 151. China Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): V Shaped Recovery
  • Table 152. China Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): U Shaped Recovery
  • Table 153. China Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): W Shaped Recovery
  • Table 154. China Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): L Shaped Recovery
  • Table 155. India Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
  • Table 156. India Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): V Shaped Recovery
  • Table 157. India Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): U Shaped Recovery
  • Table 158. India Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): W Shaped Recovery
  • Table 159. India Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): L Shaped Recovery
  • Table 160. Australia Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
  • Table 161. Australia Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): V Shaped Recovery
  • Table 162. Australia Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): U Shaped Recovery
  • Table 163. Australia Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): W Shaped Recovery
  • Table 164. Australia Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): L Shaped Recovery
  • Table 165. Singapore Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
  • Table 166. Singapore Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): V Shaped Recovery
  • Table 167. Singapore Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): U Shaped Recovery
  • Table 168. Singapore Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): W Shaped Recovery
  • Table 169. Singapore Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): L Shaped Recovery
  • Table 170. The Philippines Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
  • Table 171. The Philippines Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): V Shaped Recovery
  • Table 172. The Philippines Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): U Shaped Recovery
  • Table 173. The Philippines Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): W Shaped Recovery
  • Table 174. The Philippines Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): L Shaped Recovery
  • Table 175. South Korea Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
  • Table 176. South Korea Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): V Shaped Recovery
  • Table 177. South Korea Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): U Shaped Recovery
  • Table 178. South Korea Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): W Shaped Recovery
  • Table 179. South Korea Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): L Shaped Recovery
  • Table 180. Rest of Asia Pacific Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
  • Table 181. Rest of APAC Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): V Shaped Recovery
  • Table 182. Rest of APAC Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): U Shaped Recovery
  • Table 183. Rest of APAC Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): W Shaped Recovery
  • Table 184. Rest of APAC Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): L Shaped Recovery
  • Table 185. Latin America Precision Medicine Market Forecast by Therapeutics, 2020-2030 (US$ billion, AGR %, CAGR %)
  • Table 186. Latin America Precision Medicine Market Forecast by Technology, 2020- 2030 (US$ billion, AGR %, CAGR %)
  • Table 187. Latin America Precision Medicine Market Forecast by End Users, 2020- 2030 (US$ billion, AGR %, CAGR %)
  • Table 188. Brazil Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
  • Table 189. Brazil Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): V Shaped Recovery
  • Table 190. Brazil Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): U Shaped Recovery
  • Table 191. Brazil Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): W Shaped Recovery
  • Table 192. Brazil Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): L Shaped Recovery
  • Table 193. Mexico Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
  • Table 194. Mexico Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): V Shaped Recovery
  • Table 195. Mexico Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): U Shaped Recovery
  • Table 196. Mexico Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): W Shaped Recovery
  • Table 197. Mexico Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): L Shaped Recovery
  • Table 198. Argentina Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
  • Table 199. Argentina Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): V Shaped Recovery
  • Table 200. Argentina Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): U Shaped Recovery
  • Table 201. Argentina Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): W Shaped Recovery
  • Table 202. Argentina Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): L Shaped Recovery
  • Table 203. Rest of Latin America Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
  • Table 204. Rest of LATAM Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): V Shaped Recovery
  • Table 205. Rest of LATAM Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): U Shaped Recovery
  • Table 206. Rest of LATAM Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): W Shaped Recovery
  • Table 207. Rest of LATAM Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): L Shaped Recovery
  • Table 208. Middle East and Africa Precision Medicine Market Forecast by Therapeutics, 2020-2030 (US$ billion, AGR %, CAGR %)
  • Table 209. Middle East and Africa Precision Medicine Market Forecast by Technology, 2020-2030 (US$ billion, AGR %, CAGR %)
  • Table 210. Middle East and Africa Precision Medicine Market Forecast by End Users, 2020-2030 (US$ billion, AGR %, CAGR %)
  • Table 211. UAE Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
  • Table 212. UAE Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): V Shaped Recovery
  • Table 213. UAE Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): U Shaped Recovery
  • Table 214. UAE Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): W Shaped Recovery
  • Table 215. UAE Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): L Shaped Recovery
  • Table 216. Saudi Arabia Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): V Shaped Recovery
  • Table 217. Saudi Arabia Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): U Shaped Recovery
  • Table 218. Saudi Arabia Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): W Shaped Recovery
  • Table 219. Saudi Arabia Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): L Shaped Recovery
  • Table 220. South Africa Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): V Shaped Recovery
  • Table 221. South Africa Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): U Shaped Recovery
  • Table 222. South Africa Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): W Shaped Recovery
  • Table 223. South Africa Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): L Shaped Recovery
  • Table 224. Rest of Middle East and Africa Precision Medicine Market Forecast 2020- 2030 (US$ billion, AGR %, CAGR %)
  • Table 225. Rest of MEA Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): V Shaped Recovery
  • Table 226. Rest of MEA Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): U Shaped Recovery
  • Table 227. Rest of MEA Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): W Shaped Recovery
  • Table 228. Rest of MEA Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): L Shaped Recovery
  • Table 229. Abbott Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 230. Abbott: Financials, 2015-2019 (US$ million, AGR %)
  • Table 231. Abbott: Recent Developments (Date, Development, Details)
  • Table 232. GE Healthcare Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 233. GE Healthcare: Financials, 2015-2019 (US$ million, AGR %)
  • Table 234. GE Healthcare: Recent Developments (Date, Development, Details)
  • Table 235. Johnson & Johnson Services, Inc. Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 236. Johnson & Johnson Services, Inc.: Financials, 2015-2019 (US$ million, AGR %)
  • Table 237. Johnson & Johnson Services, Inc.: Recent Developments (Date, Development, Details)
  • Table 238. Pfizer Inc. Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 239. Pfizer Inc.: Financials, 2015-2019 (US$ million, AGR %)
  • Table 240. Pfizer Inc.: Recent Developments (Date, Development, Details)
  • Table 241. Laboratory Corporation of America Holdings Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 242. Laboratory Corporation of America Holdings: Total Company Sales 2015- 2018 (US$ million, AGR %)
  • Table 243. Laboratory Corporation of America Holdings: Recent Developments (Date, Development, Details)
  • Table 244. Danaher Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 245. Danaher: Financials, 2015-2019 (US$ million, AGR %)
  • Table 246. Danaher: Recent Developments (Date, Development, Details)
  • Table 247. Qiagen N.V. Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 248. Qiagen N.V.: Financials, 2015-2019 (US$ million, AGR %)
  • Table 249. Qiagen N.V.: Recent Developments (Date, Development, Details)
  • Table 250. Thermo Fisher Scientific Inc. Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 251. Thermo Fisher Scientific Inc.: Financials, 2015-2019 (US$ million, AGR %)
  • Table 252. Thermo Fisher Scientific Inc.: Recent Developments (Date, Development, Details)
  • Table 253. Illumina Inc. Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 254. Illumina Inc.: Financials, 2015-2019 (US$ million, AGR %)
  • Table 255. Illumina Inc.: Recent Developments (Date, Development, Details)
  • Table 256. Novartis AG Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 257. Novartis AG: Financials, 2015-2019 (US$ million, AGR %)
  • Table 258. Novartis AG: Recent Developments (Date, Development, Details)
  • Table 259. GSK Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 260. GSK: Financials, 2015-2019 (US$ million, AGR %)
  • Table 261. GSK: Recent Developments (Date, Development, Details)
  • Table 262. Merck KGaA Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 263. Merck KGaA: Financials, 2015-2019 (US$ million, AGR %)
  • Table 264. Merck KGaA: Recent Developments (Date, Development, Details)
  • Table 265. F. Hoffmann-La Roche Ltd. Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 266. F. Hoffmann-La Roche Ltd.: Financials, 2015-2019 (US$ million, AGR %)
  • Table 267. F. Hoffmann-La Roche Ltd.: Recent Developments (Date, Development, Details)
  • Table 268. Amgen Inc. Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 269. Amgen Inc.: Financials, 2015-2019 (US$ million, AGR %)
  • Table 270. Amgen Inc.: Recent Developments (Date, Development, Details)
  • Table 271. Global Precision Medicine Market CAGR Forecast by Region 2020, 2025, 2030 (CAGR %)

List of Figures

  • Figure 1. History of Precision Medicine
  • Figure 2. Key Areas of Application for Precision Medicine
  • Figure 3. Key Different Type of Data Used by Big Data Companies in Precision Medicine
  • Figure 4. Key Areas of Interest for Precision Medicine
  • Figure 5. Market Dynamics
  • Figure 6. SWOT Analysis
  • Figure 7. Porter's Analysis
  • Figure 8. PEST Analysis
  • Figure 9. Precision Medicine Market Value Chain
  • Figure 10. Global Precision Medicine Market Forecast by Therapeutics (Pre COVID- 19), 2020-2030 (US$ billion, AGR %)
  • Figure 11. Global Precision Medicine Market Forecast by Technology (Pre COVID- 19), 2020-2030 (US$ billion, AGR %)
  • Figure 12. Global Precision Medicine Market Forecast by End Users (Pre COVID- 19), 2020-2030 (US$ billion, AGR %)
  • Figure 13. Global Precision Medicine Market Forecast by Region (Pre COVID-19), 2020-2030 (US$ billion, AGR %)
  • Figure 14. Global Precision Medicine Market by Therapeutics
  • Figure 15. Global Precision Medicine Market Forecast by Therapeutics, 2020-2030 (US$ billion, AGR %)
  • Figure 16. Global Precision Medicine Market Share Forecast by Therapeutics, 2020, 2025, 2030 (%)
  • Figure 17. Cancer Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 18. Cancer Revenue Forecast 2020-2030 (US$ billion, AGR%): V Shaped Recovery
  • Figure 19. Cancer Revenue Forecast 2020-2030 (US$ billion, AGR%): U Shaped Recovery
  • Figure 20. Cancer Revenue Forecast 2020-2030 (US$ billion, AGR%): W Shaped Recovery
  • Figure 21. Cancer Revenue Forecast 2020-2030 (US$ billion, AGR%): L Shaped Recovery
  • Figure 22. Cardiovascular Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 23. Cardiovascular Revenue Forecast 2020-2030 (US$ billion, AGR%): V Shaped Recovery
  • Figure 24. Cardiovascular Revenue Forecast 2020-2030 (US$ billion, AGR%): U Shaped Recovery
  • Figure 25. Cardiovascular Revenue Forecast 2020-2030 (US$ billion, AGR%): W Shaped Recovery
  • Figure 26. Cardiovascular Revenue Forecast 2020-2030 (US$ billion, AGR%): L Shaped Recovery
  • Figure 27. CNS Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 28. CNS Revenue Forecast 2020-2030 (US$ billion, AGR%): V Shaped Recovery
  • Figure 29. CNS Revenue Forecast 2020-2030 (US$ billion, AGR%): U Shaped Recovery
  • Figure 30. CNS Revenue Forecast 2020-2030 (US$ billion, AGR%): W Shaped Recovery
  • Figure 31. CNS Revenue Forecast 2020-2030 (US$ billion, AGR%): L Shaped Recovery
  • Figure 32. Infectious Diseases Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 33. Infectious Diseases Revenue Forecast 2020-2030 (US$ billion, AGR%): V Shaped Recovery
  • Figure 34. Infectious Diseases Revenue Forecast 2020-2030 (US$ billion, AGR%): U Shaped Recovery
  • Figure 35. Infectious Diseases Revenue Forecast 2020-2030 (US$ billion, AGR%): W Shaped Recovery
  • Figure 36. Infectious Diseases Revenue Forecast 2020-2030 (US$ billion, AGR%): L Shaped Recovery
  • Figure 37. Immunology Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 38. Immunology Revenue Forecast 2020-2030 (US$ billion, AGR%): V Shaped Recovery
  • Figure 39. Immunology Revenue Forecast 2020-2030 (US$ billion, AGR%): U Shaped Recovery
  • Figure 40. Immunology Revenue Forecast 2020-2030 (US$ billion, AGR%): W Shaped Recovery
  • Figure 41. Immunology Revenue Forecast 2020-2030 (US$ billion, AGR%): L Shaped Recovery
  • Figure 42. Others Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 43. Others Revenue Forecast 2020-2030 (US$ billion, AGR%): V Shaped Recovery
  • Figure 44. Others Revenue Forecast 2020-2030 (US$ billion, AGR%): U Shaped Recovery
  • Figure 45. Others Revenue Forecast 2020-2030 (US$ billion, AGR%): W Shaped Recovery
  • Figure 46. Others Revenue Forecast 2020-2030 (US$ billion, AGR%): L Shaped Recovery
  • Figure 47. Global Precision Medicine Market by Technology
  • Figure 48. Global Precision Medicine Market Forecast by Technology, 2020-2030 (US$ billion, AGR %)
  • Figure 49. Global Precision Medicine Market Share Forecast by Technology, 2020, 2025, 2030 (%)
  • Figure 50. Companion Diagnostics Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 51. Companion diagnostics Revenue Forecast 2020-2030 (US$ billion, AGR%): V Shaped Recovery
  • Figure 52. Companion diagnostics Revenue Forecast 2020-2030 (US$ billion, AGR%): U Shaped Recovery
  • Figure 53. Companion diagnostics Revenue Forecast 2020-2030 (US$ billion, AGR%): W Shaped Recovery
  • Figure 54. Companion diagnostics Revenue Forecast 2020-2030 (US$ billion, AGR%): L Shaped Recovery
  • Figure 55. Biomarkers Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 56. Biomarkers Revenue Forecast 2020-2030 (US$ billion, AGR%): V Shaped Recovery
  • Figure 57. Biomarkers Revenue Forecast 2020-2030 (US$ billion, AGR%): U Shaped Recovery
  • Figure 58. Biomarkers Revenue Forecast 2020-2030 (US$ billion, AGR%): W Shaped Recovery
  • Figure 59. Biomarkers Revenue Forecast 2020-2030 (US$ billion, AGR%): L Shaped Recovery
  • Figure 60. Biobanking in Targeted Therapeutics Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 61. Biobanking in Targeted Therapeutics Revenue Forecast 2020-2030 (US$ billion, AGR%): V Shaped Recovery
  • Figure 62. Biobanking in Targeted Therapeutics Revenue Forecast 2020-2030 (US$ billion, AGR%): U Shaped Recovery
  • Figure 63. Biobanking in Targeted Therapeutics Revenue Forecast 2020-2030 (US$ billion, AGR%): W Shaped Recovery
  • Figure 64. Biobanking in Targeted Therapeutics Revenue Forecast 2020-2030 (US$ billion, AGR%): L Shaped Recovery
  • Figure 65. Pharmacogenomics Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 66. Pharmacogenomics Revenue Forecast 2020-2030 (US$ billion, AGR%): V Shaped Recovery
  • Figure 67. Pharmacogenomics Revenue Forecast 2020-2030 (US$ billion, AGR%): U Shaped Recovery
  • Figure 68. Pharmacogenomics Revenue Forecast 2020-2030 (US$ billion, AGR%): W Shaped Recovery
  • Figure 69. Pharmacogenomics Revenue Forecast 2020-2030 (US$ billion, AGR%): L Shaped Recovery
  • Figure 70. Molecular Diagnostics Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 71. Molecular Diagnostics Revenue Forecast 2020-2030 (US$ billion, AGR%): V Shaped Recovery
  • Figure 72. Molecular Diagnostics Revenue Forecast 2020-2030 (US$ billion, AGR%): U Shaped Recovery
  • Figure 73. Molecular Diagnostics Revenue Forecast 2020-2030 (US$ billion, AGR%): W Shaped Recovery
  • Figure 74. Molecular Diagnostics Revenue Forecast 2020-2030 (US$ billion, AGR%): L Shaped Recovery
  • Figure 75. Global Precision Medicine Market by End Users
  • Figure 76. Global Precision Medicine Market Forecast by End Users, 2020-2030 (US$ billion, AGR %)
  • Figure 77. Global Precision Medicine Market Share Forecast by End Users, 2020, 2025, 2030 (%)
  • Figure 78. Pharma & Biotech Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 79. Pharma & Biotech Revenue Forecast 2020-2030 (US$ billion, AGR%): V Shaped Recovery
  • Figure 80. Pharma & Biotech Revenue Forecast 2020-2030 (US$ billion, AGR%): U Shaped Recovery
  • Figure 81. Pharma & Biotech Revenue Forecast 2020-2030 (US$ billion, AGR%): W Shaped Recovery
  • Figure 82. Pharma & Biotech Revenue Forecast 2020-2030 (US$ billion, AGR%): L Shaped Recovery
  • Figure 83. Diagnostic Tool Companies Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 84. Diagnostic Tool Companies Revenue Forecast 2020-2030 (US$ billion, AGR%): V Shaped Recovery
  • Figure 85. Diagnostic Tool Companies Revenue Forecast 2020-2030 (US$ billion, AGR%): U Shaped Recovery
  • Figure 86. Diagnostic Tool Companies Revenue Forecast 2020-2030 (US$ billion, AGR%): W Shaped Recovery
  • Figure 87. Diagnostic Tool Companies Revenue Forecast 2020-2030 (US$ billion, AGR%): L Shaped Recovery
  • Figure 88. Healthcare IT/Big Data Companies Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 89. Healthcare IT/Big Data Companies Revenue Forecast 2020-2030 (US$ billion, AGR%): V Shaped Recovery
  • Figure 90. Healthcare IT/Big Data Companies Revenue Forecast 2020-2030 (US$ billion, AGR%): U Shaped Recovery
  • Figure 91. Healthcare IT/Big Data Companies Revenue Forecast 2020-2030 (US$ billion, AGR%): W Shaped Recovery
  • Figure 92. Healthcare IT/Big Data Companies Revenue Forecast 2020-2030 (US$ billion, AGR%): L Shaped Recovery
  • Figure 93. Clinical Laboratories Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 94. Clinical Laboratories Revenue Forecast 2020-2030 (US$ billion, AGR%): V Shaped Recovery
  • Figure 95. Clinical Laboratories Revenue Forecast 2020-2030 (US$ billion, AGR%): U Shaped Recovery
  • Figure 96. Clinical Laboratories Revenue Forecast 2020-2030 (US$ billion, AGR%): W Shaped Recovery
  • Figure 97. Clinical Laboratories Revenue Forecast 2020-2030 (US$ billion, AGR%): L Shaped Recovery
  • Figure 98. North America Precision Medicine Market Forecast by Country 2020-2030 (US$ billion, AGR %)
  • Figure 99. North America Precision Medicine Market Share Forecast by Country 2020, 2025, 2030 (%)
  • Figure 100. North America Precision Medicine Market Forecast by Therapeutics, 2020-2030 (US$ billion, AGR%)
  • Figure 101. North America Precision Medicine Market Forecast by Technology, 2020-2030 (US$ billion, AGR%)
  • Figure 102. North America Precision Medicine Market Forecast by End Users, 2020- 2030 (US$ billion, AGR%)
  • Figure 103. U.S. Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %)
  • Figure 104. U.S. Revenue Forecast 2020-2030 (US$ billion, AGR%): V Shaped Recovery
  • Figure 105. U.S. Revenue Forecast 2020-2030 (US$ billion, AGR%): U Shaped Recovery
  • Figure 106. U.S. Revenue Forecast 2020-2030 (US$ billion, AGR%): W Shaped Recovery
  • Figure 107. U.S. Revenue Forecast 2020-2030 (US$ billion, AGR%): L Shaped Recovery
  • Figure 108. Canada Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %)
  • Figure 109. Canada Revenue Forecast 2020-2030 (US$ billion, AGR%): V Shaped Recovery
  • Figure 110. Canada Revenue Forecast 2020-2030 (US$ billion, AGR%): U Shaped Recovery
  • Figure 111. Canada Revenue Forecast 2020-2030 (US$ billion, AGR%): W Shaped Recovery
  • Figure 112. Canada Revenue Forecast 2020-2030 (US$ billion, AGR%): L Shaped Recovery
  • Figure 113. Europe Precision Medicine Market Forecast by Country 2020-2030 (US$ billion, AGR %)
  • Figure 114. Europe Precision Medicine Market Share Forecast by Country 2020, 2025, 2030 (%)
  • Figure 115. Europe Precision Medicine Market Forecast by Therapeutics, 2020-2030 (US$ billion, AGR%)
  • Figure 116. Europe Precision Medicine Market Forecast by Technology, 2020-2030 (US$ billion, AGR%)
  • Figure 117. Europe Precision Medicine Market Forecast by End Users, 2020-2030 (US$ billion, AGR%)
  • Figure 118. Germany Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 119. Germany Revenue Forecast 2020-2030 (US$ billion, AGR%): V Shaped Recovery
  • Figure 120. Germany Revenue Forecast 2020-2030 (US$ billion, AGR%): U Shaped Recovery
  • Figure 121. Germany Revenue Forecast 2020-2030 (US$ billion, AGR%): W Shaped Recovery
  • Figure 122. Germany Revenue Forecast 2020-2030 (US$ billion, AGR%): L Shaped Recovery
  • Figure 123. France Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %)
  • Figure 124. France Revenue Forecast 2020-2030 (US$ billion, AGR%): V Shaped Recovery
  • Figure 125. France Revenue Forecast 2020-2030 (US$ billion, AGR%): U Shaped Recovery
  • Figure 126. France Revenue Forecast 2020-2030 (US$ billion, AGR%): W Shaped Recovery
  • Figure 127. France Revenue Forecast 2020-2030 (US$ billion, AGR%): L Shaped Recovery
  • Figure 128. UK Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %)
  • Figure 129. UK Revenue Forecast 2020-2030 (US$ billion, AGR%): V Shaped Recovery
  • Figure 130. UK Revenue Forecast 2020-2030 (US$ billion, AGR%): U Shaped Recovery
  • Figure 131. UK Revenue Forecast 2020-2030 (US$ billion, AGR%): W Shaped Recovery
  • Figure 132. UK Revenue Forecast 2020-2030 (US$ billion, AGR%): L Shaped Recovery
  • Figure 133. Italy Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %)
  • Figure 134. Italy Revenue Forecast 2020-2030 (US$ billion, AGR%): V Shaped Recovery
  • Figure 135. Italy Revenue Forecast 2020-2030 (US$ billion, AGR%): U Shaped Recovery
  • Figure 136. Italy Revenue Forecast 2020-2030 (US$ billion, AGR%): W Shaped Recovery
  • Figure 137. Italy Revenue Forecast 2020-2030 (US$ billion, AGR%): L Shaped Recovery
  • Figure 138. Spain Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %)
  • Figure 139. Spain Revenue Forecast 2020-2030 (US$ billion, AGR%): V Shaped Recovery
  • Figure 140. Spain Revenue Forecast 2020-2030 (US$ billion, AGR%): U Shaped Recovery
  • Figure 141. Spain Revenue Forecast 2020-2030 (US$ billion, AGR%): W Shaped Recovery
  • Figure 142. Spain Revenue Forecast 2020-2030 (US$ billion, AGR%): L Shaped Recovery
  • Figure 143. Belgium Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %)
  • Figure 144. Belgium Revenue Forecast 2020-2030 (US$ billion, AGR%): V Shaped Recovery
  • Figure 145. Belgium Revenue Forecast 2020-2030 (US$ billion, AGR%): U Shaped Recovery
  • Figure 146. Belgium Revenue Forecast 2020-2030 (US$ billion, AGR%): W Shaped Recovery
  • Figure 147. Belgium Revenue Forecast 2020-2030 (US$ billion, AGR%): L Shaped Recovery
  • Figure 148. Switzerland Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %)
  • Figure 149. Switzerland Revenue Forecast 2020-2030 (US$ billion, AGR%): V Shaped Recovery
  • Figure 150. Switzerland Revenue Forecast 2020-2030 (US$ billion, AGR%): U Shaped Recovery
  • Figure 151. Switzerland Revenue Forecast 2020-2030 (US$ billion, AGR%): W Shaped Recovery
  • Figure 152. Switzerland Revenue Forecast 2020-2030 (US$ billion, AGR%): L Shaped Recovery
  • Figure 153. Rest of Europe Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %)
  • Figure 154. Rest of Europe Revenue Forecast 2020-2030 (US$ billion, AGR%): V Shaped Recovery
  • Figure 155. Rest of Europe Revenue Forecast 2020-2030 (US$ billion, AGR%): U Shaped Recovery
  • Figure 156. Rest of Europe Revenue Forecast 2020-2030 (US$ billion, AGR%): W Shaped Recovery
  • Figure 157. Rest of Europe Revenue Forecast 2020-2030 (US$ billion, AGR%): L Shaped Recovery
  • Figure 158. Asia Pacific Precision Medicine Market Forecast by Country 2020-2030 (US$ billion, AGR %)
  • Figure 159. Asia Pacific Precision Medicine Market Share Forecast by Country 2020, 2025, 2030 (%)
  • Figure 160. Asia Pacific Precision Medicine Market Forecast by Therapeutics, 2020- 2030 (US$ billion, AGR%)
  • Figure 161. Asia Pacific Precision Medicine Market Forecast by Technology, 2020- 2030 (US$ billion, AGR%)
  • Figure 162. Asia Pacific Precision Medicine Market Forecast by End Users, 2020- 2030 (US$ billion, AGR%)
  • Figure 163. Japan Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %)
  • Figure 164. Japan Revenue Forecast 2020-2030 (US$ billion, AGR%): V Shaped Recovery
  • Figure 165. Japan Revenue Forecast 2020-2030 (US$ billion, AGR%): U Shaped Recovery
  • Figure 166. Japan Revenue Forecast 2020-2030 (US$ billion, AGR%): W Shaped Recovery
  • Figure 167. Japan Revenue Forecast 2020-2030 (US$ billion, AGR%): L Shaped Recovery
  • Figure 168. China Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %)
  • Figure 169. China Revenue Forecast 2020-2030 (US$ billion, AGR%): V Shaped Recovery
  • Figure 170. China Revenue Forecast 2020-2030 (US$ billion, AGR%): U Shaped Recovery
  • Figure 171. China Revenue Forecast 2020-2030 (US$ billion, AGR%): W Shaped Recovery
  • Figure 172. China Revenue Forecast 2020-2030 (US$ billion, AGR%): L Shaped Recovery
  • Figure 173. India Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %)
  • Figure 174. India Revenue Forecast 2020-2030 (US$ billion, AGR%): V Shaped Recovery
  • Figure 175. India Revenue Forecast 2020-2030 (US$ billion, AGR%): U Shaped Recovery
  • Figure 176. India Revenue Forecast 2020-2030 (US$ billion, AGR%): W Shaped Recovery
  • Figure 177. India Revenue Forecast 2020-2030 (US$ billion, AGR%): L Shaped Recovery
  • Figure 178. Australia Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %)
  • Figure 179. Australia Revenue Forecast 2020-2030 (US$ billion, AGR%): V Shaped Recovery
  • Figure 180. Australia Revenue Forecast 2020-2030 (US$ billion, AGR%): U Shaped Recovery
  • Figure 181. Australia Revenue Forecast 2020-2030 (US$ billion, AGR%): W Shaped Recovery
  • Figure 182. Australia Revenue Forecast 2020-2030 (US$ billion, AGR%): L Shaped Recovery
  • Figure 183. Singapore Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %)
  • Figure 184. Singapore Revenue Forecast 2020-2030 (US$ billion, AGR%): V Shaped Recovery
  • Figure 185. Singapore Revenue Forecast 2020-2030 (US$ billion, AGR%): U Shaped Recovery
  • Figure 186. Singapore Revenue Forecast 2020-2030 (US$ billion, AGR%): W Shaped Recovery
  • Figure 187. Singapore Revenue Forecast 2020-2030 (US$ billion, AGR%): L Shaped Recovery
  • Figure 188. The Philippines Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %)
  • Figure 189. The Philippines Revenue Forecast 2020-2030 (US$ billion, AGR%): V Shaped Recovery
  • Figure 190. The Philippines Revenue Forecast 2020-2030 (US$ billion, AGR%): U Shaped Recovery
  • Figure 191. The Philippines Revenue Forecast 2020-2030 (US$ billion, AGR%): W Shaped Recovery
  • Figure 192. The Philippines Revenue Forecast 2020-2030 (US$ billion, AGR%): L Shaped Recovery
  • Figure 193. South Korea Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %)
  • Figure 194. South Korea Revenue Forecast 2020-2030 (US$ billion, AGR%): V Shaped Recovery
  • Figure 195. South Korea Revenue Forecast 2020-2030 (US$ billion, AGR%): U Shaped Recovery
  • Figure 196. South Korea Revenue Forecast 2020-2030 (US$ billion, AGR%): W Shaped Recovery
  • Figure 197. South Korea Revenue Forecast 2020-2030 (US$ billion, AGR%): L Shaped Recovery
  • Figure 198. Rest of Asia Pacific Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %)
  • Figure 199. Rest of APAC Revenue Forecast 2020-2030 (US$ billion, AGR%): V Shaped Recovery
  • Figure 200. Rest of APAC Revenue Forecast 2020-2030 (US$ billion, AGR%): U Shaped Recovery
  • Figure 201. Rest of APAC Revenue Forecast 2020-2030 (US$ billion, AGR%): W Shaped Recovery
  • Figure 202. Rest of APAC Revenue Forecast 2020-2030 (US$ billion, AGR%): L Shaped Recovery
  • Figure 203. Latin America Precision Medicine Market Forecast by Country 2020- 2030 (US$ billion, AGR %)
  • Figure 204. Latin America Precision Medicine Market Share Forecast by Country 2020, 2025, 2030 (%)
  • Figure 205. Latin America Precision Medicine Market Forecast by Therapeutics, 2020-2030 (US$ billion, AGR%)
  • Figure 206. Latin America Precision Medicine Market Forecast by Technology, 2020- 2030 (US$ billion, AGR%)
  • Figure 207. Latin America Precision Medicine Market Forecast by End Users, 2020- 2030 (US$ billion, AGR%)
  • Figure 208. Brazil Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %)
  • Figure 209. Brazil Revenue Forecast 2020-2030 (US$ billion, AGR%): V Shaped Recovery
  • Figure 210. Brazil Revenue Forecast 2020-2030 (US$ billion, AGR%): U Shaped Recovery
  • Figure 211. Brazil Revenue Forecast 2020-2030 (US$ billion, AGR%): W Shaped Recovery
  • Figure 212. Brazil Revenue Forecast 2020-2030 (US$ billion, AGR%): L Shaped Recovery
  • Figure 213. Mexico Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %)
  • Figure 214. Mexico Revenue Forecast 2020-2030 (US$ billion, AGR%): V Shaped Recovery
  • Figure 215. Mexico Revenue Forecast 2020-2030 (US$ billion, AGR%): U Shaped Recovery
  • Figure 216. Mexico Revenue Forecast 2020-2030 (US$ billion, AGR%): W Shaped Recovery
  • Figure 217. Mexico Revenue Forecast 2020-2030 (US$ billion, AGR%): L Shaped Recovery
  • Figure 218. Argentina Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %)
  • Figure 219. Argentina Revenue Forecast 2020-2030 (US$ billion, AGR%): V Shaped Recovery
  • Figure 220. Argentina Revenue Forecast 2020-2030 (US$ billion, AGR%): U Shaped Recovery
  • Figure 221. Argentina Revenue Forecast 2020-2030 (US$ billion, AGR%): W Shaped Recovery
  • Figure 222. Argentina Revenue Forecast 2020-2030 (US$ billion, AGR%): L Shaped Recovery
  • Figure 223. Rest of Latin America Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %)
  • Figure 224. Rest of LATAM Revenue Forecast 2020-2030 (US$ billion, AGR%): V Shaped Recovery
  • Figure 225. Rest of LATAM Revenue Forecast 2020-2030 (US$ billion, AGR%): U Shaped Recovery
  • Figure 226. Rest of LATAM Revenue Forecast 2020-2030 (US$ billion, AGR%): W Shaped Recovery
  • Figure 227. Rest of LATAM Revenue Forecast 2020-2030 (US$ billion, AGR%): L Shaped Recovery
  • Figure 228. Middle East and Africa Precision Medicine Market Forecast by Country 2020-2030 (US$ billion, AGR %)
  • Figure 229. Middle East and Africa Precision Medicine Market Share Forecast by Country 2020, 2025, 2030 (%)
  • Figure 230. Middle East & Africa Precision Medicine Market Forecast by Technology, 2020-2030 (US$ billion, AGR%)
  • Figure 231. Middle East & Africa Precision Medicine Market Forecast by End Users, 2020-2030 (US$ billion, AGR%)
  • Figure 232. UAE Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %)
  • Figure 233. UAE Revenue Forecast 2020-2030 (US$ billion, AGR%): V Shaped Recovery
  • Figure 234. UAE Revenue Forecast 2020-2030 (US$ billion, AGR%): U Shaped Recovery
  • Figure 235. UAE Revenue Forecast 2020-2030 (US$ billion, AGR%): W Shaped Recovery
  • Figure 236. UAE Revenue Forecast 2020-2030 (US$ billion, AGR%): L Shaped Recovery
  • Figure 237. Saudi Arabia Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %)
  • Figure 238. Saudi Arabia Revenue Forecast 2020-2030 (US$ billion, AGR%): V Shaped Recovery
  • Figure 239. Saudi Arabia Revenue Forecast 2020-2030 (US$ billion, AGR%): U Shaped Recovery
  • Figure 240. Saudi Arabia Revenue Forecast 2020-2030 (US$ billion, AGR%): W Shaped Recovery
  • Figure 241. Saudi Arabia Revenue Forecast 2020-2030 (US$ billion, AGR%): L Shaped Recovery
  • Figure 242. South Africa Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %)
  • Figure 243. South Africa Revenue Forecast 2020-2030 (US$ billion, AGR%): V Shaped Recovery
  • Figure 244. South Africa Revenue Forecast 2020-2030 (US$ billion, AGR%): U Shaped Recovery
  • Figure 245. South Africa Revenue Forecast 2020-2030 (US$ billion, AGR%): W Shaped Recovery
  • Figure 246. South Africa Revenue Forecast 2020-2030 (US$ billion, AGR%): L Shaped Recovery
  • Figure 247. Rest of Middle East and Africa Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %)
  • Figure 248. Rest of MEA Revenue Forecast 2020-2030 (US$ billion, AGR%): V Shaped Recovery
  • Figure 249. Rest of MEA Revenue Forecast 2020-2030 (US$ billion, AGR%): U Shaped Recovery
  • Figure 250. Rest of MEA Revenue Forecast 2020-2030 (US$ billion, AGR%): W Shaped Recovery
  • Figure 251. Rest of MEA Revenue Forecast 2020-2030 (US$ billion, AGR%): L Shaped Recovery
  • Figure 252. Abbott: Financials, 2015-2019 (US$ million, AGR %)
  • Figure 253. GE Healthcare: Financials, 2015-2019 (US$ million, AGR %)
  • Figure 254. Johnson & Johnson Services, Inc.: Financials, 2015-2019 (US$ million, AGR %)
  • Figure 255. Pfizer Inc.: Financials, 2015-2019 (US$ million, AGR %)
  • Figure 256. Laboratory Corporation of America Holdings Total Company Sales 2015- 2018 (US$ million, AGR %)
  • Figure 257. Danaher: Financials, 2015-2019 (US$ million, AGR %)
  • Figure 258. Qiagen N.V.: Financials, 2015-2019 (US$ million, AGR %)
  • Figure 259. Thermo Fisher Scientific Inc. Total Company Sales 2015-2018 (US$ million, AGR %)
  • Figure 260. Illumina Inc.: Financials, 2015-2019 (US$ million, AGR %)
  • Figure 261. Novartis AG Total Company Sales 2015-2018 (US$ million, AGR %)
  • Figure 262. GSK: Financials, 2015-2019 (US$ million, AGR %)
  • Figure 263. Merck KGaA: Financials, 2015-2019 (US$ million, AGR %)
  • Figure 264. F. Hoffmann-La Roche Ltd.: Financials, 2015-2019 (US$ million, AGR %)
  • Figure 265. Amgen Inc.: Financials, 2015-2019 (US$ million, AGR %)
  • Figure 266. Global Precision Medicine Market Forecast by Region 2020-2030 (US$ billion, AGR %)
  • Figure 267. Global Precision Medicine Market Share Forecast by Region 2020, 2025, 2030 (%)